Recommendations to Streamline and Optimize USP Sterilization Informational Chapters: PDA Comments to USP and

Area of Science:

• Microbiology
• Pharmaceutical Sciences
• Regulatory Affairs

Background:

• The United States Pharmacopeia (USP) proposed consolidating sterilization informational chapters, including revised USP <1229> and <1229.1>.
• This consolidation aims to streamline guidance for moist heat sterilization processes.

Purpose of the Study:

• To critically review USP's proposed consolidation of sterilization chapters.
• To identify technical gaps, redundancies, and misalignments with global standards in the revised USP chapters.

Main Methods:

• Comparative analysis of revised USP chapters <1229> and <1229.1> against international standards (ISO 17665:2024) and PDA Technical Reports (No. 1, No. 48).
• Evaluation of coverage for key sterilization lifecycle elements and critical process parameters.

Main Results:

• The revised USP chapters lack depth compared to ISO 17665:2024 and PDA Technical Reports.
• Key lifecycle elements (qualification, cycle development, ongoing control) and critical topics (steam quality, biological indicators, process lethality) are omitted or insufficiently addressed.
• Significant technical gaps, redundancies, and misalignments with global moist heat sterilization standards were identified.

Conclusions:

• USP's goal of streamlining is acknowledged, but the current revisions create substantial deficiencies.
• Recommendations include maintaining USP <1229> as an overarching chapter and cross-referencing global standards for detailed technical requirements.
• Implementing these recommendations would enhance scientific alignment, reduce duplication, support regulatory expectations, and improve the practicality of USP sterilization guidance.